BioCryst Pharmaceuticals, Inc.
BCRX
$10.34
$0.505.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 352.57M | 238.40M | 274.75M | 212.87M | 260.04M |
| Total Receivables | 110.76M | 109.27M | 106.82M | 91.33M | 91.18M |
| Inventory | 6.06M | 5.99M | 5.40M | 5.23M | 5.04M |
| Prepaid Expenses | 14.82M | 19.11M | 17.18M | 16.50M | 12.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 479.00K | 854.00K | 201.00K | 29.75M | 29.66M |
| Total Current Assets | 484.68M | 373.63M | 404.35M | 355.68M | 398.46M |
|
|
|||||
| Total Current Assets | 484.68M | 373.63M | 404.35M | 355.68M | 398.46M |
| Net Property, Plant & Equipment | 21.67M | 22.99M | 18.99M | 19.24M | 20.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 51.50M | 47.87M | 29.66M | 31.84M | 28.62M |
| Total Assets | 557.85M | 465.05M | 514.16M | 446.42M | 457.19M |
|
|
|||||
| Total Accounts Payable | 11.46M | 10.96M | 15.83M | 5.57M | 8.59M |
| Total Accrued Expenses | 121.90M | 119.40M | 126.41M | 118.78M | 107.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 46.81M | 43.41M | 40.08M | 39.47M | 37.75M |
| Total Finance Division Other Current Liabilities | 28.68M | 21.63M | 13.74M | 26.42M | 23.71M |
| Total Other Current Liabilities | 28.68M | 21.63M | 13.74M | 26.42M | 23.71M |
| Total Current Liabilities | 208.85M | 195.39M | 196.07M | 190.24M | 177.16M |
|
|
|||||
| Total Current Liabilities | 208.85M | 195.39M | 196.07M | 190.24M | 177.16M |
| Long-Term Debt | 778.38M | 802.38M | 427.23M | 633.47M | 690.64M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.45M | 12.30M | 10.01M | 10.17M | 10.53M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.46M | 8.83M | -- | 436.00K | 454.00K |
| Total Liabilities | 1.01B | 1.02B | 633.31M | 834.31M | 878.78M |
|
|
|||||
| Common Stock & APIC | 1.70B | 1.67B | 1.39B | 1.36B | 1.34B |
| Retained Earnings | -2.15B | -2.23B | -1.51B | -1.75B | -1.76B |
| Treasury Stock & Other | -528.00K | -368.00K | 38.00K | 1.14M | 1.65M |
| Total Common Equity | -454.29M | -553.84M | -119.15M | -387.89M | -421.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -454.29M | -553.84M | -119.15M | -387.89M | -421.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -454.29M | -553.84M | -119.15M | -387.89M | -421.59M |
|
|
|||||